Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zakary L Whichard

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Letters|February 7, 2012
Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapyBrian J Park, Zakary L Whichard, Seth J Corey
Blood|January 28, 2010
Hematopoiesis and its disorders: a systems biology approachZakary L Whichard, Casim A Sarkar, Marek Kimmel, et al.
The Journal of Biological Chemistry|November 6, 2010
Slowly produced microRNAs control protein levelsZakary L Whichard, Adilson E Motter, Peter J Stein, et al.
Blood|June 4, 2011
G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphataseMuneyoshi Futami, Quan-Sheng Zhu, Zakary L Whichard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Dasatinib inhibits the growth of molecularly heterogeneous myeloid leukemiasBella S Guerrouahen, Muneyoshi Futami, Christos Vaklavas, et al.
Blood|July 25, 2013
Loss of the F-BAR protein CIP4 reduces platelet production by impairing membrane-cytoskeleton remodelingYolande Chen, Jorie Aardema, Sayali Kale, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Letters|February 7, 2012
Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapyBrian J Park, Zakary L Whichard, Seth J Corey
Blood|January 28, 2010
Hematopoiesis and its disorders: a systems biology approachZakary L Whichard, Casim A Sarkar, Marek Kimmel, et al.
The Journal of Biological Chemistry|November 6, 2010
Slowly produced microRNAs control protein levelsZakary L Whichard, Adilson E Motter, Peter J Stein, et al.
Blood|June 4, 2011
G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphataseMuneyoshi Futami, Quan-Sheng Zhu, Zakary L Whichard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Dasatinib inhibits the growth of molecularly heterogeneous myeloid leukemiasBella S Guerrouahen, Muneyoshi Futami, Christos Vaklavas, et al.
Blood|July 25, 2013
Loss of the F-BAR protein CIP4 reduces platelet production by impairing membrane-cytoskeleton remodelingYolande Chen, Jorie Aardema, Sayali Kale, et al.
Pageof 1